Founded by Flagship Pioneering, Empress re-imagines the process of small molecule drug discovery. Our bioplatform harnesses the power of evolution, human molecular and genetic data, and artificial intelligence to focus on endogenous sources of inherently drug-like small molecules as a uniquely qualified source of potential drugs.

Our mission is to generate transformative drug candidates that get to the clinic faster and cheaper, with a higher probability of success.


Biotechnology

Health Care

Empress Therapeutics

Jason Park

Teams at Empress Therapeutics

Research and Scientists

Leadership Team